Monash Ivf Group Ltd · ASX:MVF

Monash Ivf — H1 2023 Earnings Presentation

28 slides from Monash Ivf's earnings presentation, Feb 21, 2023

  1. Slide 1: Growing the future. 1HFY23 Results Presentation

    e H Monash IVF Group Growing the future. 1HFY23 Results Presentation 21 February 2023

  2. Slide 2: Acknowledgement of Country

    e 1 Monash IVF Group Acknowledgement of Country In the spirit of reconciliation, Monash IVF Group acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present and extend that respect to a

  3. Slide 3: Disclaimer

    Monash IVF Group | 1H23 Results Presentation Disclaimer .

  4. Slide 4: Executive summary

    Monash IVF Group | 1H23 Results Presentation Page 4 Executive summary • • Group • • • • Australia International • • • 1H23 • Results • • • • • • • • Invest • • in • future • growth • •

  5. Slide 5: Attractive industry fundamentals

    Monash IVF Group | 1H23 Results Presentation Page 5 Attractive industry fundamentals • • Advanced • maternal age • • • Innovation/ technology • • • Awareness and support

  6. Slide 6: Industry volumes - ARS Australia

    Monash IVF Group | 1H23 Results Presentation Page 6 Industry volumes - ARS Australia 1H20 2H20 1H21 2H21 1H22 2H22 1H23 43.9% 22,024 20,655 16,528 17,440 15,302 23.8% 24,069 24,924 23,267 18,584 19,436 19,447 3.6% 0.1% FY18 FY19 FY20 FY21 FY22 FY23 -6.2% -6.6% 1H 2H -12.3% • • • • •

  7. Slide 7: MVF market share - ARS Australia

    Monash IVF Group | 1H23 Results Presentation Page 7 MVF market share - ARS Australia • • o o • • 21.5% 20.8% 20.1% 19.6% 1H20 1H21 1H22 1H23

  8. Slide 8: Financial results

    | 9°) = inanc F results @ Monash IVF Group

  9. Slide 9: 1H23 Revenue Analysis

    Monash IVF Group | 1H23 Results Presentation Page 9 1H23 Revenue Analysis 110 105 0.0 0.1 2.0 $M 100 2.8 5.3 2.8 103.3 95 101.0 90 Reported 1H22 Industry Decline MVF Market Share Growth Price & Mix International Ultrasound DSU & Other 1H23 • o o o • •

  10. Slide 10: 1H23 EBITDA Analysis

    Monash IVF Group | 1H23 Results Presentation Page 10 1H23 EBITDA(1) Analysis 28 0.3 1.1 2.1 0.3 0.4 26 1.5 $M 2.5 26.8 26.8 24 26.1 25.3 24.3 22 1H22 Reported Non-regular items(2) 1H22 Underlying MVF Share Growth Price, Mix & Cost Industry Decline IVF Movement International Ultrasound 1H23 Underlyin

  11. Slide 11: 1H23 Profit & Loss Overview

    Monash IVF Group | 1H23 Results Presentation Page 11 1H23 Profit & Loss Overview • (1)(2)(3) • • o o o o • • •

  12. Slide 12: 1H23 Cashflow Overview

    Monash IVF Group | 1H23 Results Presentation Page 12 1H23 Cashflow Overview • 1H23 1H22 • • • • • •

  13. Slide 13: Balance Sheet Overview

    Monash IVF Group | 1H23 Results Presentation Page 13 Balance Sheet Overview • o o • 30 Jun 22 • • •

  14. Slide 14: Operational Review

    Operational Review

  15. Slide 15: Recently recruited doctors driving volumes

    Monash IVF Group | 1H23 Results Presentation Page 15 Recently recruited doctors driving volumes • o 30 24 25 20 • 15 12 11 • 10 6 7 5 • 0 FY19 FY20 FY21 FY22 FY23 (1)

  16. Slide 16: Transformation of clinic infrastructure

    Monash IVF Group | 1H23 Results Presentation Page 16 Transformation of clinic infrastructure • • • • • •

  17. Slide 17: Further improvement in Clinical pregnancy rates in CY22

    Monash IVF Group | 1H23 Results Presentation Page 17 Further improvement in Clinical pregnancy rates in CY22 resulting in 5.4% improvement since CY18 • • • 39.0 38.0 38.0 37.0 37.0 36.4 36.0 34.7 35.0 34.0 33.0 32.6 32.0 2018 2019 2020 2021 2022 (Jan-Oct)

  18. Slide 18: Investing in Brand & Marketing and our People

    Monash IVF Group | 1H23 Results Presentation Page 18 Investing in Brand & Marketing and our People • • • • • • • •

  19. Slide 19: Positive turnaround in ultrasound business

    Monash IVF Group | 1H23 Results Presentation Page 19 Positive turnaround in ultrasound business • • • • • •

  20. Slide 20: ARS International returns to growth

    Monash IVF Group | 1H23 Results Presentation Page 20 ARS International returns to growth • • • • • • • • • • • •

  21. Slide 21: Strategy and Outlook

    Strategy and Outlook FY22 Results Presentation Seay

  22. Slide 22: The most admired reproductive care provider in the world

    Monash IVF Group | 1H23 Results Presentation The most admired reproductive care provider in the world

  23. Slide 23: Outlook

    Monash IVF Group | 1H23 Results Presentation Page 23 23 Page Outlook

  24. Slide 24: Appendices

    Appendices e @ Monash IVF Group

  25. Slide 25: Treatment Mix

    Monash IVF Group | 1H23 Results Presentation Page 25 Treatment Mix

  26. Slide 26: 1H23 Earnings Reconciliation

    Monash IVF Group | 1H23 Results Presentation Page 26 1H23 Earnings Reconciliation • • • •

  27. Slide 27: Overview of Monash IVF Group

    Overview of Monash IVF Group ARS Australia 29 clinics & 4 services centres 112 Fertility Specialists (12 trainees) 7 Australian States/ Territories 3 day hospitals (SA, NSW and WA) e @ Monash IVF reoremed Grey solutions Co) ARS International 5 clinics 16 Fertility Specialists (1trainee) 5 internatio

  28. Slide 28: Slide 28

Monash IVF Group — H1 2023 Earnings Presentation on 6ix